Evidence map›Paper›PMID 29268777›Full record

ArticleJournal of medical case reports2017

Breast metastasis from squamous cell carcinoma of the oropharynx: a case report.

Raffaele Longo, Emmanuelle Melgar, Marco Campitiello, Francesca Plastino, Nada Eid, Isabelle Quirin, Laurent Hennequin, Yves Grignon, Michel Gunther, Philippe Quétin

Open access · goldAbstract readCase Reports
In one paragraph

Article in Journal of medical case reports, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.8field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Metastatic Neoplasms to the Breast.International journal of surgical pathology · 2024
    Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Raffaele LongoDivision of Medical Oncology, Centre Hospitalier Régional (CHR) Metz-Thionville, 1 Allée du Château, 57085, Ars-Laquenexy, France. raflongo@libero.it.
Emmanuelle MelgarDivision of Medical Oncology, Centre Hospitalier Régional (CHR) Metz-Thionville, 1 Allée du Château, 57085, Ars-Laquenexy, France.
Marco CampitielloDivision of Medical Oncology, Centre Hospitalier Régional (CHR) Metz-Thionville, 1 Allée du Château, 57085, Ars-Laquenexy, France.
Francesca PlastinoDivision of Medical Oncology, Centre Hospitalier Régional (CHR) Metz-Thionville, 1 Allée du Château, 57085, Ars-Laquenexy, France.
Nada EidDivision of Medical Oncology, Centre Hospitalier Régional (CHR) Metz-Thionville, 1 Allée du Château, 57085, Ars-Laquenexy, France.
Isabelle QuirinDivision of Radiology, Centre Hospitalier Régional (CHR) Metz-Thionville, 1 Allée du Château, 57085, Ars-Laquenexy, France.
Laurent HennequinDivision of Radiology, Centre Hospitalier Régional (CHR) Metz-Thionville, 1 Allée du Château, 57085, Ars-Laquenexy, France.
Yves GrignonDivision of Pathology, Centre Hospitalier Régional (CHR) Metz-Thionville, 1 Allée du Château, 57085, Ars-Laquenexy, France.
Michel GuntherDivision of Gynecology, Centre Hospitalier Régional (CHR) Metz-Thionville, 1 Allée du Château, 57085, Ars-Laquenexy, France.
Philippe QuétinDivision of Radiotherapy, Centre Hospitalier Régional (CHR) Metz-Thionville, 1 Allée du Château, 57085, Ars-Laquenexy, France.
Centre Hospitalier Régional de Metz-Thionville · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundBreast metastases from extramammary tumors are extremely rare, the most common primary tumors being contralateral breast carcinoma, followed by lung, gynecological, gastrointestinal, melanoma, and hematological cancers. Only a few cases deriving from head and neck squamous cell carcinoma have been reported in the literature to date. CASE PRESENTATION: We report a case of a 47-year-old Caucasian woman who presented to our hospital with a solitary breast lesion in the right upper external quadrant associated with multiple bone and visceral metastases. Two years before, she had undergone radical resection of a squamous cell carcinoma of the oropharynx (stage pT2, pN1), which was followed by adjuvant radiotherapy. Breast ultrasound showed a hypoechogenic tumor lesion of 4 cm in the right upper external quadrant that was associated with multiple axillary and infra-/supraclavicular adenopathies. A positron emission tomographic scan documented multiple visceral and bone metastases with a single hypermetabolic lesion of the right breast. The results of histology and immunohistochemistry were consistent with a metastasis from a squamous cell carcinoma. The patient died of acute respiratory insufficiency 1 month after her breast metastasis diagnosis and before starting any systemic antitumoral treatment.

conclusionsAlthough breast metastases are extremely rare, they should be considered in any patient with a history of cancer and confirmed by histology and immunohistochemistry because they are very difficult to distinguish from other primary breast tumors based only on clinical and radiological features. There are no standardized treatment guidelines for breast metastasis management. Surgery and radiotherapy can play a role in symptom palliation, but they do not have any relevant impact on survival, the prognosis being poor, with an estimated overall survival less than 1 year from diagnosis.

Indexed as

Bone NeoplasmsBreast NeoplasmsCarcinoma, Squamous CellFemaleHumansLung NeoplasmsLymphatic MetastasisLymph NodesMiddle AgedOropharyngeal NeoplasmsPeritoneal NeoplasmsPositron-Emission TomographySplenic NeoplasmsTomography, X-Ray ComputedWhole Body ImagingBreastHead and neckMetastasisOropharynx

Identifiers

PMID29268777
PMCPMC5740581
OpenAlexW2773955271

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.